CompletedNCT00445718
Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
Studying Neuroblastoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Children's Oncology Group
- Principal Investigator
- Jed Nuchtern, MDChildren's Oncology Group
- Intervention
- computed tomography(procedure)
- Enrollment
- 97 enrolled
- Eligibility
- All sexes
- Timeline
- 2001 – 2013
Study locations (30)
- University of Arizona Health Sciences Center, Tucson, Arizona, United States
- Southern California Permanente Medical Group, Downey, California, United States
- Children's Hospital Los Angeles, Los Angeles, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Alfred I duPont Hospital for Children, Wilmington, Delaware, United States
- Children's National Medical Center, Washington D.C., District of Columbia, United States
- Baptist Hospital of Miami, Miami, Florida, United States
- Childrens Memorial Hospital, Chicago, Illinois, United States
- Advocate Lutheran General Hospital, Park Ridge, Illinois, United States
- Southern Illinois University, Springfield, Illinois, United States
- Maine Children's Cancer Program, Scarborough, Maine, United States
- Dana-Farber Cancer Institute, Boston, Massachusetts, United States
- University of Massachusetts Medical School, Worcester, Massachusetts, United States
- Saint Peter's University Hospital, New Brunswick, New Jersey, United States
- Newark Beth Israel Medical Center, Newark, New Jersey, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI)
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00445718 on ClinicalTrials.govOther trials for Neuroblastoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2, PHASE3NCT07549321A Safety and Efficacy Study of hu14 in High-Risk Neuroblastoma PatientsRenaissance Pharma Ltd.
- RECRUITINGPHASE1, PHASE2NCT06625190Alpha/Beta T and B Cell Depletion With Zoledronic Acid for Solid TumorsUniversity of Florida
- RECRUITINGPHASE1NCT07172958Selective Antigen Specific T Cells and CAR T Cells in Subjects With Relapsed/Refractory Embryonal Tumors (SABRE)Children's National Research Institute
- RECRUITINGPHASE2NCT07085338A Phase II Study With a Safety Run-In of the Addition of N-803 to a Chemoimmunotherapy Backbone for the Treatment of Patients With Relapsed or Refractory NeuroblastomaSt. Jude Children's Research Hospital
- RECRUITINGPHASE1, PHASE2NCT07399821An Imaging Study of Anti-GD2-800CW in Patients With NeuroblastomaPrincess Maxima Center for Pediatric Oncology
- RECRUITINGPHASE1NCT06995872Phase I Trial of rhIL-15 Plus Dinutuximab Plus Irinotecan/Temozolomide for Children and Young Adults With Relapsed/Refractory NeuroblastomaNational Cancer Institute (NCI)
- RECRUITINGPHASE1, PHASE2NCT06814496Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing TumorsUniversity of Arizona
- RECRUITINGPHASE1NCT07087002GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young AdultsStanford University